HIGH-DOSE EPIRUBICIN (E) GIVEN AS A DAILY X 3 SCHEDULE IN PATIENTS (PTS) WITH UNTREATED EXTENSIVE NON-SMALL CELL LUNG-CANCER (NSCLC) - A PHASE-I-II STUDY Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • FELD, R
  • WIERZBICKI, R
  • WALDE, D
  • SHEPHERD, F
  • Evans, William
  • BURKES, R
  • HOLLOWAY, C
  • LASSUS, M

publication date

  • March 1988